FdaApplication

NDA 202788

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBTCP PHARMA LLC
application_typeNDA
approval_date2012-01-04

Products (7)

ProductActive ingredientStrengthDosage form
SUBSYSFENTANYL0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SPRAY;SUBLINGUAL
SUBSYSFENTANYL0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SPRAY;SUBLINGUAL
SUBSYSFENTANYL1.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SPRAY;SUBLINGUAL
SUBSYSFENTANYL0.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SPRAY;SUBLINGUAL
SUBSYSFENTANYL0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SPRAY;SUBLINGUAL
SUBSYSFENTANYL0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SPRAY;SUBLINGUAL
SUBSYSFENTANYL1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SPRAY;SUBLINGUAL

7 products